Jane Street’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-71,741
Closed -$196K 12092
2025
Q4
$313K Buy
+71,741
New +$388K ﹤0.01% 8745
2025
Q3
Sell
-10,774
Closed -$30.9K 11124
2025
Q2
$30.9K Sell
10,774
-59,473
-85% -$157K ﹤0.01% 9283
2025
Q1
$190K Buy
+70,247
New +$264K ﹤0.01% 8493
2024
Q3
Sell
-73,174
Closed -$143K 9876
2024
Q2
$143K Buy
+73,174
New +$249K ﹤0.01% 8601
2023
Q3
Sell
-7,226
Closed -$236K 8896
2023
Q2
$236K Buy
+7,226
New +$203K ﹤0.01% 7464

Other funds holding GNLX

Jane Street's GNLX Position: Q1 2026 in Review

Jane Street sold out of Genelux (GNLX) in Q1 2026, closing a stake of 71,741 shares — an estimated $196K sold.

Jane Street first reported a position in GNLX in Q2 2023 and held it in 5 quarters. The position peaked at $313K in Q4 2025. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Jane Street reported no remaining Genelux position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 71,741 Genelux shares in Q1 2026, an estimated $196K.
  • Jane Street first reported a position in Genelux in Q2 2023 and held it in 5 quarters.
  • Jane Street's Genelux position peaked at $313K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.